eISSN 2329-0358

Logo



Get your full text copy in PDF

Two decades of experience in Mucormycosis after kidney transplantation

Behzad Einollahi, Mahboob Lessan-Pezeshki, Jafar Aslani, Eghlim Nemati, Zohreh Rostami, Mohammad Javad Hosseini, Mohammad Hassan Ghadiani, Pedram Ahmadpour, Heshmatollah Shahbazian, Fatemeh Pour-Reza-Gholi, Mohammad Reza Ghanji, Ammir Hossein Miladipour, Nader Nouri-Majalan

Ann Transplant 2011; 16(3): 44-48

ID: 881994


Background:    Invasive mucormycosis is a very rare infection after kidney transplantation. Here, we report 25 renal transplant recipients with mucormycosis; to our knowledge, this is the largest reported population of mucormycosis in these patients.
    Material/Methods:    In a retrospective study, we collected all kidney transplants with mucormycosis from 9 Transplant Centers of Iran from 1990 to 2010. The definitive diagnosis of mucormycosis was established by obtaining a biopsy specimen of the involved tissue.
    Results:    The most form of disease was rhino-cerebral (n =13), followed by pulmonary (n=7). Overall mortality rate was 52% (n=13), particularly in recipients with pulmonary infection (100%); however, the mortality rate in rhino-cerebral form of disease was low (30.8%). There was no statistically significant difference in mortality rate between male and female (P=0.8). In addition, no significant differences were seen in mortality rate with age of patients (p=0.8) and time of diagnosis since transplantation (p=0.3). Pulmonary infection was more seen in recipients received azathioprine compared to those on mycophenolate mofetil (p=0.006).
    Conclusions:    Mucormycosis after renal transplantation has a poor prognosis, particularly patients with pulmonary involvement.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree